Mastering Renal History Taking for MRCP PACES Station 2

admin
Renal MRCP PACES
1558 words • 7 min read

Article Content

Published by TalkingCases

Jul 02, 2026

Mastering Renal History Taking for MRCP PACES Station 2

Why Renal Histories Are High-Yield in PACES

Station 2 of the MRCP PACES examination tests your ability to take a focused, structured history from a patient surrogate within 20 minutes — followed by a discussion with the examiner. Renal presentations are a favourite among examiners because they demand a systematic approach, integrate multiple systems (cardiovascular, endocrine, rheumatological), and require you to demonstrate senior-level clinical reasoning.

Common renal scenarios encountered include:

  • Chronic kidney disease (CKD) with complex comorbidities

  • Nephrotic syndrome (proteinuria, oedema)

  • Acute kidney injury (AKI) in a hospitalised patient

  • Recurrent urinary tract infections or haematuria

  • Renal colic and urological overlap presentations

  • Post-transplant complications

  • Drug-induced nephropathy


The Examiner's Perspective: What Scores You Marks

Examiners at Station 2 are assessing four key domains:

  1. Clinical communication skills — Can you build rapport, use open questions, and summarise effectively?

  2. History-taking structure — Is your history logical, comprehensive, and focused?

  3. Clinical reasoning — Can you generate a sensible differential and narrow it down?

  4. Managing patient concerns — Do you address the patient's ideas, concerns, and expectations (ICE)?

A common error is treating Station 2 as a mere data-gathering exercise. The examiner wants to see you think like a registrar, not a medical student on autopilot.


A Structured Framework for Renal History Taking

1. Introduction and Consent

Begin with a confident, professional introduction:

"Good morning, my name is Dr [Name], I'm one of the medical doctors. I've been asked to come and speak with you today to understand more about the problem you've been experiencing. Would that be alright?"

Top tip: Maintain eye contact, sit at the patient's level, and use open body language throughout.


2. Presenting Complaint (PC) and History of Presenting Complaint (HPC)

Start with an open question:

"Can you tell me in your own words what's been happening?"

Let the patient speak for 30–60 seconds without interruption. This alone can earn you marks for communication.

Renal-Specific HPC Probes

Depending on the presenting complaint, explore the following systematically:

For oedema or nephrotic-range proteinuria:

  • Onset (sudden vs gradual), progression, and distribution (periorbital, lower limbs, sacral, genital)

  • Associated foamy urine

  • Recent infections (especially pharyngitis — think post-streptococcal GN)

  • Weight changes

For haematuria:

  • Visible (macroscopic) vs non-visible (microscopic)

  • Timing in the urinary stream (initial — urethral; terminal — bladder; throughout — upper tract)

  • Presence of clots

  • Associated pain (painless haematuria → consider malignancy until proven otherwise)

  • Trauma, vigorous exercise, or menstruation (exclude transient causes)

** For AKI or CKD presentations:**

  • Fatigue, lethargy, pruritus (uraemic symptoms)

  • Changes in urine output (oliguria, anuria, polyuria, nocturia)

  • Nausea, vomiting, metallic taste

  • Bone pain (renal osteodystrophy in CKD)

  • Easy bruising or bleeding (uraemic platelet dysfunction)

For recurrent UTIs or dysuria:

  • Frequency, urgency, dysuria, hesitancy, incomplete emptying

  • Flank pain, rigors, fevers

  • Haematuria

  • Sexual history relevance (honeymoon cystitis, atrophic vaginitis in postmenopausal women)


3. Past Medical History (PMH)

This is where you demonstrate your understanding of renal risk factors. Ask about:

Category Conditions to Elicit
Cardiovascular Hypertension, ischaemic heart disease, heart failure, peripheral vascular disease
Metabolic/Endocrine Diabetes mellitus (type 1 or 2, duration, control), gout, hypercalcaemia
Autoimmune/Rheumatological SLE, rheumatoid arthritis, ANCA-associated vasculitis, Goodpasture's syndrome
Malignancy Myeloma, renal cell carcinoma, bladder cancer
Previous renal events AKI episodes, kidney stones, UTIs, recurrent infections
Other Chronic NSAID use, BPH, prior urinary tract surgery

4. Drug History

This is critical in renal histories and often underexplored.

Ask specifically about:

  • Nephrotoxic medications: NSAIDs, lithium, ACE inhibitors/ARBs, aminoglycosides, ciclosporin/tacrolimus, tenofovir, proton pump inhibitors (interstitial nephritis)

  • Anticoagulants: Warfarin, DOACs (if haematuria is present — could be benign or mask underlying pathology)

  • Immunosuppressants: If post-transplant or glomerulonephritis

  • Over-the-counter and herbal remedies: Some Chinese herbal medicines and high-dose vitamin C are nephrotoxic

  • Recreational drugs: Heroin (focal segmental glomerulosclerosis), cocaine (rhabdomyolysis)

  • Recent contrast exposure: Contrast-induced nephropathy


5. Family History

Renal conditions with strong hereditary components include:

  • Autosomal dominant polycystic kidney disease (ADPKD) — Ask about family members requiring dialysis or transplantation

  • Alport syndrome — Sensorineural hearing loss and haematuria in family members

  • Familial hypercalciuria or nephrolithiasis

  • Diabetes and hypertension (indirect renal risk)


6. Social History

Don't just tick a box — tailor your social history to the renal context:

  • Occupation: Heavy metal exposure (lead, cadmium), dye industry (bladder cancer — aniline dyes)

  • Smoking: Bladder cancer, renal cell carcinoma, cardiovascular risk

  • Alcohol: Hepatitis B/C risk, pancreatitis-induced AKI

  • Travel: Schistosomiasis (haematuria), malaria (AKI), tuberculosis

  • Diet: High-protein diets (hyperfiltration injury), high-salt intake (hypertension), star fruit (nephrotoxicity)

  • Sexual history: If suspicion of STI-related glomerulonephritis (e.g., post-gonococcal), HIV-associated nephropathy, Hepatitis B/C-related membranous nephropathy

  • Intravenous drug use: HCV, HBV, HIV, endocarditis-related GN

  • Impact on daily life: Can they work? Drive? Manage their medications independently?


7. Systems Review

Complete with a targeted systems review:

  • Respiratory: Haemoptysis (Goodpasture's, ANCA vasculitis)

  • Rheumatological: Joint pains, rash, oral ulcers (SLE)

  • ENT: Epistaxis, sinusitis (granulomatosis with polyangiitis)

  • Neurological: Neuropathy (diabetes, vasculitis), sensory loss

  • Dermatological: Purpura (Henoch-Schönlein purpura), livedo reticularis (cholesterol emboli)


Presenting Your History to the Examiner

The presentation is where many candidates gain or lose the most marks. Use a clear structure:

Template

"My name is [Name]. I took a history from Mrs [Name], a [age]-year-old [occupation] who presents with [PC].

In summary, Mrs [Name] has had [concise summary of HPC in 2–3 sentences].

Of significance in her past medical history, she has [relevant conditions]. Her medications include [relevant drugs, especially nephrotoxic ones]. There is a family history of [relevant]. Socially, she [relevant positives].

My differential diagnosis would be:

  1. [Most likely]

  2. [Second most likely]

  3. [Must-not-miss]

To further evaluate, I would [initial investigations — bloods, urine, imaging]. I would specifically [targeted tests based on differentials]."


High-Yield Renal Differentials for Common Presentations

Persistent Proteinuria

  1. Diabetic nephropathy (long-standing diabetes, retinopathy)

  2. Glomerulonephritis (membranous, IgA nephropathy, minimal change — check for malignancy association)

  3. Hypertensive nephrosclerosis

  4. Amyloidosis (especially if chronic inflammatory condition)

Painless Haematuria

  1. Urological malignancy (bladder, renal cell — must refer under 2-week wait)

  2. Glomerulonephritis (IgA nephropathy — synchronous with URTI)

  3. BPH

  4. Anticoagulant therapy (diagnosis of exclusion)

Acute Kidney Injury

  1. Pre-renal (hypovolaemia, sepsis, heart failure)

  2. Intrinsic (ATN from nephrotoxins, acute interstitial nephritis, glomerulonephritis)

  3. Post-renal (BPH, stones, malignancy — always do a bladder scan)


Common Pitfalls That Cost Candidates Marks

Pitfall How to Avoid
Failing to ask about nephrotoxic drugs Always specifically ask: "Do you take any painkillers regularly, like ibuprofen?"
Missing hereditary conditions If patient mentions a family member on dialysis, ask more — consider ADPKD
Ignoring social impact Ask: "How has this affected your day-to-day life?"
Not addressing patient concerns Always ask: "Was there anything particular you were worried about?"
Presenting an unstructured summary Practise a standard template until it becomes automatic
Overlooking transplant history Ask about transplant date, immunosuppression, rejection episodes, graft function

Key Investigations to Mention in Your Discussion

Demonstrating knowledge of appropriate investigations shows examiner-ready competence:

Bedside:

  • Urine dipstick (protein, blood, leucocytes, nitrites, glucose)

  • Urine ACR/PCR (quantify proteinuria)

  • Blood pressure measurement

  • Bladder scan (post-void residual)

Bloods:

  • U&E, eGFR, FBC

  • CRP, immunoglobulins, serum electrophoresis, serum free light chains (myeloma screen)

  • Autoimmune screen: ANA, ANCA, anti-GBM, complement (C3, C4)

  • HbA1c, lipid profile

  • Hepatitis B/C and HIV serology

  • Bicarbonate, calcium, phosphate, PTH (CKD-MBD)

Imaging:

  • Renal ultrasound (size, symmetry, obstruction, cysts)

  • CT KUB (stones, masses)

  • CT urogram or cystoscopy (if haematuria — urology referral)

  • Renal biopsy (if glomerular disease suspected and kidneys are appropriately sized)


Final Tips for Success

  1. Practise your timing — 15 minutes for history, 5 minutes for discussion. Set a timer.

  2. Use AI patient simulations — Online platforms now offer realistic patient encounters that can help you refine your questioning flow without the pressure of a real patient.

  3. Keep a renal history template — Memorise the structure above and adapt it to the scenario.

  4. Think aloud during the presentation — Examiners want to hear your clinical reasoning, not just facts.

  5. Don't forget the patient's perspective — Ideas, Concerns, and Expectations (ICE) are not optional; they're scored.


Conclusion

Renal history taking in MRCP PACES Station 2 rewards structure, clinical reasoning, and patient-centred communication. By integrating a systematic approach with renal-specific questioning — and presenting with clarity and confidence — you'll demonstrate the competencies expected of a UK medical registrar.

Remember: the examiner isn't looking for perfection. They're looking for safety, structure, and sensible thinking. Master those, and you'll walk out of Station 2 with the marks you need.


Good luck with your PACES preparation. For more high-yield PACES content, bookmark our blog and subscribe to our newsletter.

Share

Keep your MRCP PACES reading path deliberate

This article belongs to the MRCP PACES consultation and communication cluster. Move back to the PACES hub for scope, browse only PACES articles, or switch into deliberate rehearsal inside TalkingCases.

Related Articles

Continue your medical education journey with these carefully curated insights

11 min read

MRCP PACES: Essential Mental Capacity Act Guidelines Explained

MRCP PACES: Essential Mental Capacity Act Guidelines ExplainedWhy Mental Capacity Matters in MRCP PACESIf you are preparing for MRCP PACES, you already know that ethical …

6 min read

Recent Advances in Frailty Assessment: MRCP PACES Update

Recent Advances in Frailty Assessment: A High-Yield MRCP PACES UpdateWhy Frailty Matters in MRCP PACESFrailty has become one of the most heavily examined topics in …

8 min read

Mastering Palliative Care Symptom Management for MRCP PACES

Mastering Palliative Care Symptom Management for MRCP PACESWhy Palliative Care is High-Yield in MRCP PACESPalliative care scenarios appear frequently in MRCP PACES, particularly in Stations …

Join the Discussion

Share your thoughts and insights with the medical community

Comments